ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2023
[Changes of intestinal wall barrier function and its correlation with susceptibility to infection in patients with cirrhotic portal hypertension].
X Y Lin, C Li, T Zhang, J Chen, J J Jiang, Q Zheng
Open access · greenAbstract readEnglish Abstract
In one paragraphArticle in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors at 1 institution in 1 country.
X Y LinDepartment of Hepatology, Hepatology Research Institute, the First Affiliated Hospital, Fujian Medical University, Fujian Clinical Research Center for Hepatology and Intestinal Diseases, Fuzhou 350005, China.
C LiDepartment of Hepatology, Hepatology Research Institute, the First Affiliated Hospital, Fujian Medical University, Fujian Clinical Research Center for Hepatology and Intestinal Diseases, Fuzhou 350005, China.
T ZhangDepartment of Hepatology, Hepatology Research Institute, the First Affiliated Hospital, Fujian Medical University, Fujian Clinical Research Center for Hepatology and Intestinal Diseases, Fuzhou 350005, China.
J ChenDepartment of Hepatology, Hepatology Research Institute, the First Affiliated Hospital, Fujian Medical University, Fujian Clinical Research Center for Hepatology and Intestinal Diseases, Fuzhou 350005, China.
J J JiangDepartment of Hepatology, Hepatology Research Institute, the First Affiliated Hospital, Fujian Medical University, Fujian Clinical Research Center for Hepatology and Intestinal Diseases, Fuzhou 350005, China.
Q ZhengDepartment of Hepatology, Hepatology Research Institute, the First Affiliated Hospital, Fujian Medical University, Fujian Clinical Research Center for Hepatology and Intestinal Diseases, Fuzhou 350005, China.
Fujian Medical University · CN
Funding
Leading Project Foundation of Science and Technology, Fujian Province 2019Y0014Startup Fund for Scientific Research of Fujian Medical University 2018QH1052
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Hypertension, PortalLipopolysaccharide ReceptorsBiomarkersC-Reactive ProteinHumansLiver CirrhosisNitric Oxide Synthase Type IIProspective StudiesBiomarkersC-Reactive ProteinLipopolysaccharide ReceptorsNitric Oxide Synthase Type IIClinically significant portal hypertensionInfectionIntestinal permeabilityLiver cirrhosisMacrophages
Identifiers
PMID36948852
PMCPMC12813921
OpenAlexW4360600185
What OpenQuestion holds
Textmetadata
Read underepoch 390